Applied DNA Sciences, Inc. (APDN) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Applied DNA Sciences, Inc. (APDN) Bundle
Whether you're an investor or an analyst, this (APDN) DCF Calculator is your go-to resource for accurate valuation. Loaded with real data from Applied DNA Sciences, Inc., you can adjust forecasts and observe the effects in real time.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.9 | 9.0 | 18.2 | 13.4 | 3.4 | 4.3 | 5.3 | 6.7 | 8.3 | 10.4 |
Revenue Growth, % | 0 | 367.4 | 101.25 | -26.43 | -74.33 | 24.81 | 24.81 | 24.81 | 24.81 | 24.81 |
EBITDA | -12.2 | -11.7 | -12.7 | -9.6 | -14.0 | -3.8 | -4.7 | -5.9 | -7.4 | -9.2 |
EBITDA, % | -634.19 | -129.41 | -69.79 | -71.75 | -408.72 | -88.31 | -88.31 | -88.31 | -88.31 | -88.31 |
Depreciation | .3 | .8 | 1.3 | 1.4 | .0 | .4 | .4 | .6 | .7 | .9 |
Depreciation, % | 14.79 | 9.35 | 7.1 | 10.19 | 0 | 8.29 | 8.29 | 8.29 | 8.29 | 8.29 |
EBIT | -12.5 | -12.5 | -14.0 | -11.0 | -14.0 | -3.9 | -4.9 | -6.1 | -7.6 | -9.5 |
EBIT, % | -648.98 | -138.76 | -76.89 | -81.94 | -408.72 | -91.77 | -91.77 | -91.77 | -91.77 | -91.77 |
Total Cash | 7.8 | 6.6 | 15.2 | 7.2 | 6.4 | 3.5 | 4.4 | 5.5 | 6.8 | 8.5 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | .2 | 2.8 | 3.1 | .3 | .4 | .6 | .8 | .9 | 1.2 | 1.5 |
Account Receivables, % | 10.06 | 31.06 | 16.88 | 1.91 | 10.55 | 14.09 | 14.09 | 14.09 | 14.09 | 14.09 |
Inventories | .5 | 1.4 | .6 | .3 | .4 | .5 | .6 | .8 | 1.0 | 1.2 |
Inventories, % | 25.75 | 15.17 | 3.31 | 2.47 | 12.78 | 11.9 | 11.9 | 11.9 | 11.9 | 11.9 |
Accounts Payable | 1.3 | 1.4 | 1.7 | 1.1 | 1.2 | 1.1 | 1.4 | 1.8 | 2.2 | 2.7 |
Accounts Payable, % | 64.72 | 15.01 | 9.6 | 8.02 | 33.97 | 26.26 | 26.26 | 26.26 | 26.26 | 26.26 |
Capital Expenditure | -1.1 | -2.5 | -.5 | -.1 | -.4 | -.8 | -1.1 | -1.3 | -1.6 | -2.0 |
Capital Expenditure, % | -55.07 | -28.23 | -2.69 | -0.58686 | -11.89 | -19.69 | -19.69 | -19.69 | -19.69 | -19.69 |
Tax Rate, % | -1.94 | -1.94 | -1.94 | -1.94 | -1.94 | -1.94 | -1.94 | -1.94 | -1.94 | -1.94 |
EBITAT | -12.3 | -14.1 | -14.2 | -10.9 | -14.3 | -3.9 | -4.9 | -6.1 | -7.6 | -9.5 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -12.5 | -19.1 | -12.5 | -7.2 | -14.8 | -4.8 | -5.5 | -6.8 | -8.5 | -10.7 |
WACC, % | 5.45 | 5.5 | 5.5 | 5.48 | 5.5 | 5.49 | 5.49 | 5.49 | 5.49 | 5.49 |
PV UFCF | ||||||||||
SUM PV UFCF | -30.3 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | -11 | |||||||||
Terminal Value | -312 | |||||||||
Present Terminal Value | -239 | |||||||||
Enterprise Value | -269 | |||||||||
Net Debt | -6 | |||||||||
Equity Value | -264 | |||||||||
Diluted Shares Outstanding, MM | 4 | |||||||||
Equity Value Per Share | -66.46 |
What You Will Get
- Real APDN Financial Data: Pre-filled with Applied DNA Sciences’ historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Applied DNA Sciences’ intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Comprehensive DCF Calculator: Features both unlevered and levered DCF valuation models tailored for Applied DNA Sciences, Inc. (APDN).
- WACC Calculator: Ready-to-use Weighted Average Cost of Capital sheet with adjustable parameters.
- Customizable Forecast Assumptions: Adjust growth projections, capital expenditures, and discount rates as needed.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios specific to Applied DNA Sciences, Inc. (APDN).
- Interactive Dashboard and Charts: Visual representations that condense key valuation metrics for straightforward analysis.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered Applied DNA Sciences data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for Applied DNA Sciences’ intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose This Calculator?
- User-Friendly Interface: Tailored for both novices and seasoned professionals.
- Customizable Inputs: Adjust parameters effortlessly to suit your analytical needs.
- Real-Time Valuation: Observe immediate updates to Applied DNA Sciences’ valuation as you tweak inputs.
- Preloaded Financials: Comes with Applied DNA Sciences’ (APDN) actual financial data for swift evaluations.
- Relied Upon by Experts: Utilized by investors and analysts for making well-informed choices.
Who Should Use This Product?
- Investors: Evaluate Applied DNA Sciences, Inc. (APDN) for informed investment decisions.
- CFOs and Financial Analysts: Enhance valuation methodologies and assess financial forecasts.
- Startup Founders: Gain insights into the valuation strategies of established companies like Applied DNA Sciences, Inc. (APDN).
- Consultants: Provide comprehensive valuation analyses for clients in the biotech sector.
- Students and Educators: Utilize actual market data to learn and teach valuation practices.
What the Template Contains
- Historical Data: Includes Applied DNA Sciences, Inc.'s (APDN) past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Applied DNA Sciences, Inc.'s (APDN) intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Applied DNA Sciences, Inc.'s (APDN) financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.